π΅οΈ Cytokinetics Inc ($CYTK)
SEC insider & ownership activity, last 12 months Β· CIK 1061983 Β· every row links its SEC filing
Over the last 12 months insiders sold $42.4M with no open-market buying against it. Callos Andrew sold $14.2M through a 10b5-1 trading plan in 23 lots (DecβJul). 1 planned sale is pending, the largest $3.1M (Sung Lee). No red-flag 8-Ks in the window.
π¨ 2 signals active β
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) Β· 9 sellers, $42.4M (86 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Callos Andrew | 0 | β | 23 | $14.2M | Jul 1, 2026 |
| Robert I. Blum | 0 | β | 20 | $9.5M | Jul 27, 2026 |
| Lee Sung | 0 | β | 5 | $5.7M | Jul 1, 2026 |
| Malik Fady Ibraham | 0 | β | 22 | $4.2M | Jul 21, 2026 |
| Kaye Edward M. Md | 0 | β | 6 | $3.5M | Jun 1, 2026 |
| John T. Henderson | 0 | β | 2 | $2.1M | May 5, 2026 |
| Wierenga Wendell | 0 | β | 3 | $1.9M | May 5, 2026 |
| Parshall B Lynne | 0 | β | 3 | $1.0M | Jun 1, 2026 |
| Harrington Robert Arthur | 0 | β | 2 | $248K | Dec 1, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| T. ROWE Price Investment Management, Inc. | 14.5% | 13G | Feb 17, 2026 | filing β | |
| Vanguard Capital Management | 5.2% | 13G | Apr 29, 2026 | filing β | |
| FMR LLC | exited | 13G | Jul 8, 2026 | filing β | |
| Abigail P. Johnson | exited | 13G | Jul 8, 2026 | filing β |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Fady Malik | $2.1M | Jul 7, 2026 | filing β |
| Robert Blum | $4.5M | Jul 1, 2026 | filing β |
| Sung Lee | $781K | Jun 29, 2026 | filing β |
| Sung Lee | $541K | Jun 26, 2026 | filing β |
| Sung Lee | $3.1M | Jun 24, 2026 | filing β |
| Edward Kaye | $225K | Jun 1, 2026 | filing β |
| Wendell Wierenga | $266K | May 5, 2026 | filing β |
| John Henderson | $1.3M | May 5, 2026 | filing β |
| Sung Lee | $1.6M | May 5, 2026 | filing β |
| Andrew Callos | $5.3M | Apr 15, 2026 | filing β |
| Fady Malik | $1.4M | Apr 7, 2026 | filing β |
| Robert Blum | $3.0M | Apr 1, 2026 | filing β |
| Andrew Callos | $229K | Mar 31, 2026 | filing β |
| Andrew Callos | $120K | Mar 18, 2026 | filing β |
| Andrew Callos | $103K | Mar 16, 2026 | filing β |
| B Lynne Parshall | $622K | Mar 2, 2026 | filing β |
| Andrew Callos | $3.8M | Jan 2, 2026 | filing β |
| Andrew Callos | $114K | Dec 29, 2025 | filing β |
| Wendell Wierenga | $1.3M | Dec 22, 2025 | filing β |
| Andrew Callos | $3.6M | Dec 5, 2025 | filing β |
| John T Henderson | $578K | Dec 2, 2025 | filing β |
| Edward Kaye | $1.9M | Dec 1, 2025 | filing β |
| B Lynne Parshall | $331K | Nov 19, 2025 | filing β |
| Edward Kaye | $322K | Nov 11, 2025 | filing β |
| Wendell Wierenga | $253K | Oct 27, 2025 | filing β |
| Fady Malik | $653K | Oct 21, 2025 | filing β |
| Edward Kaye | $385K | Oct 6, 2025 | filing β |
| Robert Blum | $824K | Oct 1, 2025 | filing β |
| Edward Kaye | $361K | Sep 30, 2025 | filing β |
| Robert Harrington | $152K | Sep 2, 2025 | filing β |
| Edward Kaye | $239K | Sep 2, 2025 | filing β |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | May 27, 2026 | filing β |
| Other events (8.01) | May 6, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing β |
| Other events (8.01) | May 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing β |
| Earnings (2.02) | May 5, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing β |
| Earnings (2.02) | Feb 24, 2026 | filing β |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing β |
| Other events (8.01) | Feb 17, 2026 | filing β |
| Other events (8.01) | Dec 19, 2025 | filing β |
| Other events (8.01) | Dec 12, 2025 | filing β |
| Officer/director changes (5.02) | Nov 13, 2025 | filing β |
| Earnings (2.02) | Nov 5, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing β |
| Material agreement (1.01) | Sep 16, 2025 | filing β |
| New financial obligation (2.03) | Sep 16, 2025 | filing β |
| Unregistered equity sale (3.02) | Sep 16, 2025 | filing β |
| Other events (8.01) | Sep 16, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Sep 16, 2025 | filing β |
| Other events (8.01) | Sep 15, 2025 | filing β |
| Other events (8.01) | Aug 31, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 31, 2025 | filing β |
| Other events (8.01) | Aug 31, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 31, 2025 | filing β |
| Other events (8.01) | Aug 30, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 30, 2025 | filing β |
| Officer/director changes (5.02) | Aug 19, 2025 | filing β |
| Earnings (2.02) | Aug 7, 2025 | filing β |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing β |